The Future of Anxiolytic Drug Therapy

References

• American Psychiatric Association. Task Force Report on Benzodiazepine Dependence, Toxicity, and Abuse. American Psychiatric Association, Washington, DC 1984a
   Google Scholar
• Ancill R. J. J., Embury G. D., Macewan G. W., Kennedy J. S. Lorazepam in the elderly—a retrospective study of the side-effects in 20 patients. Journal of Pharmacology 1990; 2: 126–127
   Google Scholar
• Anon. Cost of neurosis. Lancet 1987; i: 23
   Google Scholar
• Arana G. W., Epstein S., Molloy M., Greenblatt D. J. Carbamazepine-induced reduction of plasma alprazolam concentrations: a clinical case report. Journal of Clinical Psychiatry 1988; 4(9)448–449
   Google Scholar
• Ashton H. Benzodiazepine withdrawal: an unfinished story. British Medical Journal 1984; 28(8)1135–1140
   Google Scholar
• Ashton H. Benzodiazepine withdrawal: outcome in 50 patients. British Journal of Addiction 1987; 8(2)665–671
   Google Scholar
• Ashton H. A physician's view of the treatment of benzodiazepine dependence. Presented at the Spring Meeting, Royal College of Psychiatrists. 1988. London
   Google Scholar
• Ashton H. Risks of dependence on benzodiazepine drugs: a major problem of long-term treatment. British Medical Journal 1989; 29(8)103–104
   Google Scholar
• Ayd F. J., Jr. Benzodiazepines: dependence and withdrawal. Journal of the American Medical Association 1979; 24(2)1401–1402
   Google Scholar
• Ayd F. J., Jr. Benzodiazepine prescribing. International Drug Therapy Newsletter 1989; 2(4)41–42
   Google Scholar
• Baldessarini R. J. Drugs and the treatment of psychiatric disorders. The Pharmacological Basis of Therapeutics, A. G. Oilman, L. S. Goodman, A. Oilman. Macmillan, New York 1980
   Google Scholar
• Baldwin H. A., File S. E. Reversal of increased anxiety during benzodiazepine withdrawal: evidence for an anxiogenic endogenous ligand for the benzodiazepine receptor. Brain Research Bulletin 1988; 20: 603–608
   PubMed Web of Science ®Google Scholar
• Beardsley R. S., Gardocki G. J., Larson D. B., Hidalgo J. Prescribing of psychotropic medication by primary care physicians and psychiatrists. Archives of General Psychiatry 1988; 4(5)1117–1119
   Google Scholar
• Beers M., Avorn J., Soumerai S. B., et al. Psychoactive medication use in intermediate-care facility residents. Journal of the American Medical Association 1988; 260: 3016–3020
   PubMed Web of Science ®Google Scholar
• Bo O., Haffner O., Langard O., . Ethanol and diazepam as causative agents in road accidents. Alcohol, Drugs, and Traffic Safety, S Iraelstam, S. Lambert, et al. Addiction Research Foundation of Ontario, Toronto 1975
   Google Scholar
• Bowden C. L., Fisher J. G. Safety and efficacy of long-term diazepam therapy. Southern Medical Journal 1980; 7(3)1581–1584
   Google Scholar
• Brosan L., Broadbent D., Nutt D., et al. Performance effects of diazepam during and after prolonged administration. Psychological Medicine 1986; 16: 561–671
   PubMed Web of Science ®Google Scholar
• Busto U., Fornazzari L., Naranjo C. A. Protracted tinnitus after discontinuation of long-term therapeutic use of benzodiazepines. Journal of Clinical Psychopharmacology 1988; 5: 359–362
   Google Scholar
• Cassano G. B., Castrogiovanni P., Conti I. Drug responses in different anxiety states under benzodiazepine treatment: some multivariate analyses for evaluation of Rating Scale for Depression scores. The Benzodiazepines, E Garratini, S Mussini, L. O. Randall. Raven Press, New York 1973
   Google Scholar
• Chouinard G. Additional comments on benzodiazepine withdrawal. Canadian Medical Association Journal 1988; 13(9)119–120
   Google Scholar
• Ciccone P. E. Misuse and abuse of benzodiazepines. American Journal of Psychiatry 1987; 144: 1246
   PubMed Web of Science ®Google Scholar
• Committee on the Review of Medicines. Systematic review of the benzodiazepines. British Medical Journal 1980; 280: 910–912
   PubMedGoogle Scholar
• Cohen M. R. Medication error reports. Hospital Pharmacy 1988; 2(3)91–92
   Google Scholar
• DeCourcy Hinds M. Anxiety rises as New York limits tranquilizer prescriptions. New York Times 1989; 35, January 21
   Google Scholar
• Dement W. C., Carskadon M. A., Mitler M. M., et al. Prolonged use of flurazepam: a sleep laboratory study. Behavioral Medicine 1978; 5: 25–31
   Google Scholar
• File S. E. Tolerance to the behavioral actions of benzodiazepines. Neuroscience and Biobehavioral Review 1985; 9: 113–121
   PubMed Web of Science ®Google Scholar
• Fontaine R., Annable L., Beaudry P., et al. Efficacy and withdrawal of two potent benzodiazepines: premazepam and lorazepam. Psychopharmacology Bulletin 1985; 21: 91–92
   PubMedGoogle Scholar
• Fontaine R., Chouinard G., Annable L. Rebound anxiety in anxious patients after abrupt withdrawal of benzodiazepine treatment. American Journal of Psychiatry 1984; 198(4)848–852
   Google Scholar
• Foy A., Drinkwater V., March S., Mearrick P. Confusion after admission to hospital in elderly patients using benzodiazepines. British Medical Journal 1986; 293: 1072
   PubMed Web of Science ®Google Scholar
• Gallager D. W., Heninger K., Heninger G. Periodic benzodiazepine antagonist administration prevents benzodiazepine withdrawal symptoms in primates. European Journal of Pharmacology 1986; 132: 31
   PubMed Web of Science ®Google Scholar
• Garvey M. J., Tollefson G. D. Prevalence of misuse of prescribed benzodiazepines in patients with primary anxiety disorder or major depression. American Journal of Psychiatry 1986; 14(3)1601–1603
   Google Scholar
• Golombok S., Moodley P., Lader M. Cognitive impairment in long-term benzodiazepiae users. Psychological Medicine 1988; 1(8)365–374
   Google Scholar
• Gullick E. L., King L. J. Appropriateness of drugs prescribed by primary care physicians for depressed patients. Journal of Affective Disorders 1979; 1: 55–58
   PubMed Web of Science ®Google Scholar
• Herman J. B., Rosenbaum J. F., Brotman A. W. The alprazolam to clonazepam switch for the treatment of panic disorder. Journal of Clinical Psycho-pharmacology 1987; 7: 175–178
   PubMed Web of Science ®Google Scholar
• Higgitt A. C., Lader M. H., Fonagy P. Clinical management of benzodiazepine dependence. British Medical Journal 1985; 29(1)688–690
   Google Scholar
• Howell E. F., Laraia M., Ballenger J. C., Lydiard R. B. Lorazepam treatment of panic disorder. Presented at the New Research Session, American Psychiatric Association Meeting, Chicago, 1987
   Google Scholar
• Jerkovich G., Preskorn S. Failure of buspirone to protect against lorazepam withdrawal symptoms. Journal of the American Medical Association 1987; 25(8)204–205
   Google Scholar
• Johnstone E. C., Cunningham Owens D. G., Frith C. D., et al. Neurotic illness and its response to anxiolytic and antidepressant treatment. Psychological Medicine 1980; 10: 321–328
   PubMed Web of Science ®Google Scholar
• Kahn R. J., McNair D. M., Lipman R. S., et al. Imipramine and chlordiazepoxide in depressive and anxiety disorders: 2. Efficacy in anxious outpatients. Archives of General Psychiatry 1986; 43: 79–85
   PubMed Web of Science ®Google Scholar
• Kales A., Bixler E. O., Scharf M., Kales J. D. Sleep laboratory studies of flurazepam: a model for evaluating hypnotic drugs. Clinical Pharmacology and Therapeutics 1976a; 1(9)576–583
   Google Scholar
• Kales A., Kales J. D., Bixler E. O., et al. Hypnotic efficacy of triazolam: sleep laboratory evaluation of intermediate-term effectiveness. Journal of Clinical Pharmacology 1976b; 16: 399–406
   PubMed Web of Science ®Google Scholar
• Kales A., Bixler E. O., Soldatos C. R., et al. Dose-response studies of lormetazepam: efficacy, side effects, and rebound insomnia. Journal of Clinical Pharmacology 1982a; 22: 520–530
   PubMed Web of Science ®Google Scholar
• Kales A., Bixler E. O., Soldatos C. R., et al. Quazepam and flurazepam: long-term use and extended withdrawal. Clinical Pharmacology and Therapeutics 1982b; 32: 781–788
   PubMed Web of Science ®Google Scholar
• Kales A., Soldatos C. R., Bixler E. O., et al. Early morning insomnia with rapidly eliminated benzodiazepines. Science 1983a; 220: 95–97
   PubMed Web of Science ®Google Scholar
• Kales A., Soldatos C. R., Bixler E. O., et al. Midazolam: dose-response studies of effectiveness and rebound insomnia. Pharmacology 1983b; 26: 138–149
   PubMed Web of Science ®Google Scholar
• Kales A., Soldatos C. R., Vela-Bueno A. Clinical comparison of benzodiazepine hypnotics with short and long elimination half-lives. The Benzodiazepines. Current Standards for Medical Practice, D. E. Smith, D. R. Wesson. MTP Press, Lancaster 1986a
   Google Scholar
• Kales A., Bixler E. O., Vela-Bueno A., et al. Comparison of short and long half-life benzodiazepine hypnotics: triazolam and quazepam. Clinical Pharmacology and Therapeutics 1986b; 40: 378–386
   PubMed Web of Science ®Google Scholar
• Kales A., Bixler E. O., Soldatos C. R., et al. Lorazepam: effects on sleep and withdrawal phenomena. Pharmacology 1986c; 32: 121–130
   PubMed Web of Science ®Google Scholar
• Kales A., Bixler E. O., Vela-Bueno A., et al. Alprazolam: effects on sleep and withdrawal phenomena. Journal of Clinical Pharmacology 1987; 27: 508–515
   PubMed Web of Science ®Google Scholar
• Keller M. B., Klerman G. L., Lavori P. W., et al. Treatment received by depressed patients. Journal of the American Medical Association 1982; 248: 1848–1855
   PubMed Web of Science ®Google Scholar
• Kemper N., Poser W., Poser S. Benzodiazepin-abhaengigkeit. Deutsche Medizinische Wochenschrift 1980; 10(5)1707–1712
   Google Scholar
• Klein E., Uhde T. W., Post R. M. Preliminary evidence for the utility of carbamazepine in alprazolam withdrawal. American Journal of Psychiatry 1986; 14(3)235–236
   Google Scholar
• Klerman G. L., Ballenger J. C., Burrows G. D., et al. In reply. Archives of General Psychiatry 1989; 46: 670–672
   Google Scholar
• Lader M. H., Petursson H. Benzodiazepine derivatives—side effects and dangers. Biological Psychiatry 1981; 1(6)1195–1201
   Google Scholar
• Lader M. H., Ron M., Petursson H. Computed axial brain tomography in long-term benzodiazepine users. Psychological Medicine 1984; 1(4)203–206
   Google Scholar
• Lamb R. J., Griffiths R. R. Effects of repeated Ro 15–1788 administration in benzodiazepine-dependent baboons. European Journal of Pharmacology 1985; 110: 257
   PubMed Web of Science ®Google Scholar
• Langer S. Z., Arbilla S., Scatton B., et al. Zolpidem, a novel hypnotic. Presented at the 1989 Meeting of the American College of Neuropsychopharmacology. 1989
   Google Scholar
• Larson E., Kukull W. A., Buchner D., et al. Adverse drug reactions associated with global cognitive impairment in elderly persons. Annals of Internal Medicine 1987; 107: 169–173
   PubMed Web of Science ®Google Scholar
• Laughren T. P., Battey Y., Greenblatt D. J., et al. A controlled trial of diazepam withdrawal in chronically anxious outpatients. Acta Psychiatrica Scan-dinavica 1982; 65: 171–179
   PubMed Web of Science ®Google Scholar
• Le Goc L, Feline A., Frebault D., et al. Caracteristiques de la consommation de benzodiazepines chez des patients hospitalises dans un service de medicine interne. Encephale 1985; ii: 1–6
   Google Scholar
• Linnoila M., Erwin C. W., Brendle A., et al. Psychomotor effects of diazepam in anxious patients and healthy volunteers. Journal of Clinical Psychopharmacology 1983; 3: 88–96
   PubMed Web of Science ®Google Scholar
• Lucki I., Rickels K., Geller A. M. Chronic use of benzodiazepines and psychomotor and cognitive test performance. Psychopharmacology 1986; 8(8)416–433
   Google Scholar
• Lydiard R. B., Laraia M. T., Ballenger J. C., Howell E. F. Emergence of depressive symptoms in patients receiving alprazolam for panic disorder. American Journal of Psychiatry 1987; 14(4)664–665
   Google Scholar
• Mant A., Duncan-Jones P., Saltman D., et al. Development of long term use of psychotropic drugs by general practice patients. British Medical Journal 1988; 296: 603–606
   PubMedGoogle Scholar
• Marks I. M., De Albuquerque A., Cottraux J., et al. The ‘efficacy’ of alprazolam in panic disorder and agoraphobia: a critique of recent reports. Archives of General Psychiatry 1989; 46: 668–670
   PubMed Web of Science ®Google Scholar
• Marttila J. K., Hammel R. J., Alexander B., et al. Potential untoward effects of long-term use of flurazepam in geriatric patients. Journal of the American Pharmacology Association 1977; 17: 692–695
   Web of Science ®Google Scholar
• McGillion F. Aspects of the current status of benzodiazepine therapy. Drugs Today 1989; 25: 27
   Google Scholar
• McNair D. M. Anti-anxiety drugs and human performance. Archives of General Psychiatry 1973; 2(9)609–617
   Google Scholar
• Mellinger G. D., Balter M. B., Uhlenhuth E. H. Prevalence and correlates of the long-term use of anxiolytics. Journal of the American Medical Association 1984; 25(1)375–379
   Google Scholar
• Mellman T. A., Uhde T. W. Withdrawal syndrome with gradual tapering of alprazolam. American Journal of Psychiatry 1986; 14(3)1464–1466
   Google Scholar
• Mellor C. S., Jain V. K. Diazepam withdrawal syndrome. Its prolonged and changing nature. Canadian Medical Association Journal 1982; 12(7)1093–1096
   Google Scholar
• Miller F., Whitcup S. Benzodiazepine use in psychiatrically hospitalized elderly patients. Journal of Clinical Psychopharmacology 1986; 6: 384–385
   PubMed Web of Science ®Google Scholar
• Moran M. G., Thompson T. L., Mies A. S. Sleep disorders in the elderly. American Journal of Psychiatry 1988; 14(5)1369–1378
   Google Scholar
• Morgan K., Owsald I. Anxiety caused by a short-life hypnotic. British Medical Journal 1982; 284: 942
   PubMedGoogle Scholar
• Morgan K., Dallosso H., Ebrahim S., et al. Prevalence, frequency, and duration of hypnotic drug use among the elderly living at home. British Medical Journal 1988; 296: 601–602
   PubMed Web of Science ®Google Scholar
• Morris H. H., Estes M. L. Traveler's amnesia: transient global amnesia secondary to triazolam. Journal of the American Medical Association 1987; 25(8)945–946
   Google Scholar
• Morris H. H., Estes M. L. Letters to the Editor. Journal of the American Medical Association 1988; 25(9)351–352
   Google Scholar
• Moskowitz H., Smiley A. Effects of chronically administered buspirone and diazepam in driving-related skills performance. Journal of Clinical Psychopharmacology 1982; 4((12, sec. 2))45–55
   Google Scholar
• Murphy S. M., Owen R., Tyrer P. Withdrawal symptoms after six weeks treatment with diazepam. Lancet 1984; ii: 1389
   Google Scholar
• Noyes R., Clancy J., Coryell W. H., et al. A withdrawal syndrome after abrupt discontinuation of alprazolam. American Journal of Psychiatry 1985; 142: 114–116
   PubMed Web of Science ®Google Scholar
• Nun J. D., Costello M. J. Rapid induction of lorazepam dependence and reversal with flumenazil. Life Sciences 1988; 43: 1045
   PubMed Web of Science ®Google Scholar
• O'Hanlon J. F., Haak T. W., Blaauw G. J., et al. Diazepam impairs lateral position control in highway driving. Science 1982; 217: 79–81
   PubMed Web of Science ®Google Scholar
• Olajide D., Lader M. Depression following withdrawal from long-term benzodiazepine use: a report of four cases. Psychological Medicine 1984; 14: 937–940
   PubMed Web of Science ®Google Scholar
• Pecknold J. C, McClure D. J., Fleuri D., et al. Benzodiazepine withdrawal effects. Progress in Neuro-psychopharmacology and Biological Psychiatry 1982; 6: 517–522
   PubMed Web of Science ®Google Scholar
• Pecknold J. C., Swinson R. P., Kuch K., Lewis C. P. Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. Archives of General Psychiatry 1988; 4(5)429–436
   Google Scholar
• Perera K. M. H., Powell T., Jenner F. A. Computerized axial tomographic studies following long-term use of benzodiazepines. Psychological Medicine 1987; 1(7)775–777
   Google Scholar
• Petursson H., Gudjonsson G. H., Lader M. H. Psychological performance during withdrawal from long-term benzodiazepine treatment. Psychopharmacology 1983; 8(1)345–349
   Google Scholar
• Pollack M. H., Rosenbaum J. F. Benzodiazepines in panic-related disorders. Journal of Anxiety Disorders 1988; 2: 95–107
   Google Scholar
• Poser W., Poser S., Roscher D., Argyrakis A. Do benzodiazepines cause cerebral atrophy?. Lancet 1983; i: 715
   Google Scholar
• Power K. G., Jerrom D. W. A., Simpson R. J., et al. Controlled study of withdrawal symptoms and rebound anxiety after six week course of diazepam for generalized anxiety. British Medical Journal 1985; 290: 1246–1248
   PubMed Web of Science ®Google Scholar
• Rashid K., Patrissi G., Cook B. Multiple serious symptom formation with alprazolam. Presented at the 1988 Annual Meeting of the American Psychiatric Association, Montreal. 1988
   Google Scholar
• Ray W. A., Griffin M. R., Downey M. Benzodiazepines of long and short elimination half-life and the risk of hip fracture. Journal of the American Medical Association 1989; 26(2)3303–3307
   Google Scholar
• Ray W. A., Griffin M. R., Schaffner W., et al. Psychotropic drug use and the risk of hip fracture. New England Journal of Medicine 1987; 316: 363–369
   PubMed Web of Science ®Google Scholar
• Rickels K. Buspirone, clorazepate and withdrawal. Presented at the Annual Meeting of the American Psychiatric Association, Dallas, Texas, 18–24 May, 1985
   Google Scholar
• Rickels K. Antianxiety therapy: potential value of long-term treatment. Journal of Clinical Psychiatry 1987; 4(8)7–11
   Google Scholar
• Rickels K., Case G., Downing R. W., Winokur A. Long-term diazepam therapy and clinical outcome. Journal of the American Medical Association 1983; 250: 767–771
   PubMed Web of Science ®Google Scholar
• Rickels K., Case W. G., Schweizer E. E., et al. Low-dose dependence in chronic benzodiazepine users: a preliminary report on 119 patients. Psychopharmacology Bulletin 1986; 22: 407–415
   PubMed Web of Science ®Google Scholar
• Rickels K., Fox I. L., Greenblatt D. J., et al. Clorazepate and lorazepam: clinical improvement and rebound anxiety. American Journal of Psychiatry 1988a; 145: 312–317
   PubMed Web of Science ®Google Scholar
• Rickels K., Schweizer E., Case G. W., Garcia-Espana F. Benzodiazepine dependence, withdrawal severity, and clinical outcome: effects of personality. Psychopharmacology Bulletin 1988b; 24: 415–420
   PubMedGoogle Scholar
• Rodrigo E. K., King M. B., Williams P. Health of long-term benzodiazepine users. British Medical Journal 1988; 29(6)603–606
   Google Scholar
• Ron M. The alcoholic brain: CT scan and psychological findings. Psychological Medicine Monograph Supplemen. Cambridge University Press, Cambridge 1983
   Google Scholar
• Schatzberg A. F., Cole J. O. Benzodiazepines in depressive disorders. Archives of General Psychiatry 1978; 2(4)509–514
   Google Scholar
• Schmauss C., Krieg J. C. Enlargement of cerebrospinal fluid spaces in long-term benzodiazepine users. Psychological Medicine 1987; 1(7)869–873
   Google Scholar
• Schmauss C., Apelt S., Emrich H. M. Characterization of benzodiazepine withdrawal in high-and low-dose dependent psychiatric inpatients. Brain Research Bulletin 1987; 19: 393–400
   PubMed Web of Science ®Google Scholar
• Schneider-Helmert D. Why low-dose benzodiazepine-dependent insomniacs can't escape their sleeping pills. Acta Psychiatrica Scandinavica 1988; 7(8)706–711
   Google Scholar
• Schweizer E., Rickels K. Failure of buspirone to manage benzodiazepine withdrawal. American Journal of Psychiatry 1986; 25(8)204–205
   Google Scholar
• Schweizer E., Case W. G., Rickels K. Dr. Schweizer and associates reply. American Journal of Psychiatry 1989; 146: 1242
   PubMed Web of Science ®Google Scholar
• Schweizer E., Rickels K., Lucki I. Resistance to the anti-anxiety effect of buspirone in patients with a history of benzodiazepine use. New England Journal of Medicine 1986; 31(4)719–720
   Google Scholar
• Skegg D. C. G., Richards S. M., Doll R. Minor tranquillisers and road accidents. British Medical Journal 1979; i: 917–919
   Google Scholar
• Sunter J. P., Bal T. S., Cowan W. K. Three cases of fatal triazolam poisoning. British Medical Journal 1988; 297: 719
   PubMed Web of Science ®Google Scholar
• Taylor F. K. The damnation of benzodiazepines. British Journal of Psychiatry 1989; 15(4)697–704
   Google Scholar
• Tyrer P. Towards rational therapy with monoamine oxidase inhibitors. British Journal of Psychiatry 1976; 12(8)354–360
   Google Scholar
• Tyrer P. Dependence as a limiting factor in the clinical use of minor tranquilizers. Pharmacology and Therapeutics 1988; 3(6)173–188
   Google Scholar
• Tyrer P. J., Seivewright N. Identification and management of benzodiazepine dependence. Postgraduate Medicine 1984; 60: 41–46
   Google Scholar
• Tyrer P., Casey P. R., Seivewright H., Seivewright N. A survey of the treatment of anxiety disorders in general practice. Postgraduate Medical Journal 1988; 64((suppl 2))27–31
   PubMedGoogle Scholar
• Tyrer P., Owen R., Dawling S. Gradual withdrawal of diazepam after long-term therapy. Lancet 1983; i: 1402–1406
   Google Scholar
• Uhde T. W., Kellner C. H. Cerebral ventricular size in panic disorder. Journal of Affective Disorders 1987; 1(2)175–178
   Google Scholar
• Uhlenhuth E. H., Dewit H., Balter M. B., et al. Risks and benefits of long-term benzodiazepine use. Journal of Clinical Psychopharmacology 1988; 8: 161–167
   PubMed Web of Science ®Google Scholar
• Warren R. Drugs detected in fatally injured drivers in the province of Ontario. Alcohol, Drugs, and Traffic Safety, L. Goldberg. Almquist and Wiskell, Stockholm 1981; Vol. 1
   Google Scholar
• Weissman M. M., Klerman G. L. The chronic depressive in the community: unrecognized and poorly treated. Comprehensive Psychiatry 1977; 1(8)523–532
   Google Scholar
• Weissman M. M., Myers J. K., Thompson W. D. Depression and its treatment in a US urban community. Archives of General Psychiatry 1981; 3(8)417–421
   Google Scholar
• Wells B. G., Evans R. L., Ereshefsky L., et al. Clinical outcome and adverse effect profile associated with concurrent administration of alprazolam and imipramine. Journal of Clinical Psychiatry 1988; 49: 394–399
   PubMed Web of Science ®Google Scholar
• Woods J. H., Katz J. L., Winger G. Abuse liability of benzodiazepines. Pharmacological Reviews 1987; 39: 251–413
   PubMed Web of Science ®Google Scholar
• Woods J. H., Katz J. L., Winger G. Use and abuse of benzodiazepines. Issues relevant to prescribing. Journal of the American Medical Association 1988; 260: 3476–3480
   PubMed Web of Science ®Google Scholar